Predicting the in vivo release from a liposomal formulation by IVIVC and non-invasive positron emission tomography imaging

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 1, 2010, Pages 71-77

  Hühn, Eva ^a   Buchholz, Hans Georg ^b   Shazly, Gamal ^a   Maus, Stephan ^b   Thews, Oliver ^b   Bausbacher, Nicole ^b   Rösch, Frank ^a   Schreckenberger, Mathias ^b   Langguth, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Convolution; Dissolution; In vitro in vivo correlation (IVIVC); Liposome; Positron emission tomography (PET); Release

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LIPOSOME; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG RELEASE; FREEZE THAWING; HYDROGENATION; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; NONHUMAN; PARTICLE SIZE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RAT; ANIMAL; PROCEDURES;

ANIMALS; FLUORODEOXYGLUCOSE F18; LIPOSOMES; PARTICLE SIZE; POSITRON-EMISSION TOMOGRAPHY; RATS;

EID: 77954761515     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.05.020     Document Type: Article

References (25)

1. Allen T.M., Cleland L.G. Serum-induced leakage of liposome contents. Biochim. Biophys. Acta 1980, 597:418-426.
2. Bergstrom M., Yates R., Wall A., Kagedal M., Syvanen S., Langstrom B. Blood-brain barrier penetration of zolmitriptan-modelling of positron emission tomography data. J. Pharmacokinet. Pharmacodyn. 2006, 33:75-91.
3. Burgess D.J., Crommelin D.J., Hussain A.S., Chen M.L. Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report. AAPS J. 2004, 6:100-111.
4. Damen J., Regts J., Scherphof G. Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins Dependence on cholesterol content and phospholipid composition. Biochim. Biophys. Acta 1981, 665:538-545.
5. Drummond D.C., Noble C.O., Hayes M.E., Park J.W., Kirpotin D.B. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J. Pharm. Sci. 2008, 97:4696-4740.
6. El Maghraby G.M., Barry B.W., Williams A.C. Liposomes and skin: from drug delivery to model membranes. Eur. J. Pharm. Sci. 2008, 34:203-222.
7. EMEA Note for Guidance on Quality of Modified Release Products. A: Oral Dosage Forms. B: Transdermal Dosage Forms 1999.
8. FDA Guidance for Industry. Extended Release Oral Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations 1997.
9. Funato K., Yoda R., Kiwada H. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta 1992, 1103:198-204.
10. Garidel P., Hildebrand A., Knauf K., Blume A. Membranolytic activity of bile salts: influence of biological membrane properties and composition. Molecules (Basel, Switzerland) 2007, 12:2292-2326.
11. Gillespie W.R. Convolution-based approaches for in vivo-in vitro correlation modeling. Adv. Exp. Med. Biol 1997, 423:53-65.
12. Langenbucher F. Handling of computational in vitro/in vivo correlation problems by Microsoft Excel. I. Principles and some general algorithms. Eur. J. Pharm. Biopharm. 2002, 53:1-7.
13. Langenbucher F. Handling of computational in vitro/in vivo correlation problems by Microsoft Excel. II. Distribution functions and moments. Eur. J. Pharm. Biopharm. 2003, 55:77-84.
14. Langenbucher F. Handling of computational in vitro/in vivo correlation problems by Microsoft Excel. III. Convolution and deconvolution. Eur. J. Pharm. Biopharm. 2003, 56:429-437.
15. Langenbucher, F., 2009. IVIVC/Excel Documentation. Available from: http://sites.google.com/site/friederlangenbucher/.
16. Martinez M., Rathbone M., Burgess D., Huynh M. In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. J. Control Release 2008, 129:79-87.
17. Mayer L.D., Hope M.J., Cullis P.R., Janoff A.S. Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim. Biophys. Acta 1985, 817:193-196.
18. O'Hara T., Hayes S., Davis J., Devane J., Smart T., Dunne A. In vivo-in vitro correlation (IVIVC) modeling incorporating a convolution step. J. Pharmacokinet. Pharmacodyn. 2001, 28:277-298.
19. Patel A.J., Lazdunski M., Honore E. Lipid and mechano-gated 2P domain K(+) channels. Curr. Opin. Cell Biol. 2001, 13:422-428.
20. Penefsky H.S. Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase. J. Biol. Chem. 1977, 252:2891-2899.
21. Rosso L., Brock C.S., Gallo J.M., Saleem A., Price P.M., Turkheimer F.E., Aboagye E.O. A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients. Cancer Res. 2009, 69:120-127.
22. Scherphof G., Roerdink F., Waite M., Parks J. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim. Biophys. Acta 1978, 542:296-307.
23. Shazly G., Nawroth T., Langguth P. Comparison of dialysis and dispersion methods for in vitro release determination of drugs from multilamellar liposomes. Dissolution Technol. 2008, 15:4.
24. Veng-Pedersen P., Gobburu J.V., Meyer M.C., Straughn A.B. Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approach. Biopharm. Drug Dispos. 2000, 21:1-6.
25. Washington C. Drug release from microdisperse systems: a critical review. Int. J. Pharm. 1990, 58:12.